Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation
about
Cytomegalovirus infection in transplant recipientsInfection in Organ Transplantation.Dynamic prediction of recurrent events data by landmarking with application to a follow-up study of patients after kidney transplant.Detecting the Hidden Properties of Immunological Data and Predicting the Mortality Risks of Infectious Syndromes.Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.Immune Repertoire Profiling Reveals that Clonally Expanded B and T Cells Infiltrating Diseased Human Kidneys Can Also Be Tracked in BloodValidation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patientsProphylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients.Altered Intracellular ATP Production by Activated CD4+ T-Cells in Very Preterm Infants.Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine.Expanding role of cytomegalovirus as a human pathogen.Minipigs in Translational Immunosafety Sciences: A Perspective.Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses.Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications.Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study.Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies.Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.Immune monitoring of infectious complications in transplant patients: An important step towards improved clinical management.Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection.Anellovirus loads are associated with outcomes in pediatric lung transplantation.Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates.Immune risk phenotype in kidney transplant recipients: a reliable surrogate for premature immune senescence and increased susceptibility to infection?Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.
P2860
Q26801802-624C19A9-468A-43E6-9B1C-D21E67796B1CQ30238810-87BC2A5D-AF80-4651-94AE-BC4839E46F9EQ31090112-07CD33C1-CD8B-428A-8ADA-EB8D352CF93BQ31112206-BFAE457B-0CEF-4036-A8E0-81E1F4CE394CQ35715908-838212AA-8DC5-4AB2-B974-CAEC984DC177Q35850731-B35EC834-9B56-402B-AE27-0BB873EA89A6Q36299933-B15541C7-07E1-4192-AACB-EA06E61C4F45Q37203522-FF4781E1-54EC-4B32-BD12-F6A75A5D6C2AQ37533828-121BF017-399F-4A5D-8F0C-B21DFD25568FQ37641415-4A68F771-59BE-42D1-BE46-B7E7B19A588AQ38673038-68A2BFFB-4DC5-4C56-8281-2D8D3C950001Q38721243-5CEC98DA-E06E-495B-B4B7-C443C9F0BD61Q40358580-C9C2D2C2-8C67-434E-B674-AE8967A12B1DQ40484597-56662F03-F020-4502-8E49-92F19421987BQ40630330-F0E5839E-E9FF-467C-972C-20377D19AE7EQ40645930-7B6041FB-48D7-47A4-8882-D3D161BDD669Q40721769-D80E07EC-1186-4488-A56B-FF7D71711E86Q40763955-0FC17C11-DF4B-40E4-A91E-EAAD65FA2CA2Q41930205-76F22291-70B5-4851-9652-7730D5EF7A40Q42366690-CD58AB10-C254-46BB-BC50-36A6AB0B8469Q43646903-0A04EC25-305C-4D67-808B-F5EB74ED32AEQ47552304-90477A00-3A97-4B38-BBB2-941FD2660B73Q47557661-C985BD79-57DD-4A6F-BD16-E98322C9C4ECQ47596410-16458C9E-40D8-48B8-8809-FF4DCE0CAF40Q50998540-351F96A6-B092-498D-943E-A6BBE8DC6E39Q54503112-736BB75A-3CEA-4E15-8709-055B82BF4DDDQ55084357-940A70F3-A9D3-4B4C-B4B2-0F8C5F328767
P2860
Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical immune-monitoring str ...... in solid organ transplantation
@ast
Clinical immune-monitoring str ...... in solid organ transplantation
@en
Clinical immune-monitoring str ...... in solid organ transplantation
@nl
type
label
Clinical immune-monitoring str ...... in solid organ transplantation
@ast
Clinical immune-monitoring str ...... in solid organ transplantation
@en
Clinical immune-monitoring str ...... in solid organ transplantation
@nl
prefLabel
Clinical immune-monitoring str ...... in solid organ transplantation
@ast
Clinical immune-monitoring str ...... in solid organ transplantation
@en
Clinical immune-monitoring str ...... in solid organ transplantation
@nl
P2093
P2860
P3181
P356
P1476
Clinical immune-monitoring str ...... in solid organ transplantation
@en
P2093
Atul Humar
Deepali Kumar
Mario Fernández-Ruiz
P2860
P3181
P356
10.1038/CTI.2014.3
P407
P577
2014-02-01T00:00:00Z